Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines

scientific article published on 01 December 1996

Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8968076

P2093author name stringGlinsky GV
Mossine VV
Price JE
Kiriakova G
Metcalf JB
Glinsky VV
P433issue23
P921main subjectcancer metastasisQ120912394
P304page(s)5319-5324
P577publication date1996-12-01
P1433published inCancer ResearchQ326097
P1476titleInhibition of human breast cancer metastasis in nude mice by synthetic glycoamines
P478volume56

Reverse relations

cites work (P2860)
Q35945071Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.
Q35759428Galectin-4 in normal tissues and cancer
Q35763903Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.
Q34771717Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers
Q34768486Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs
Q39011785Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3.
Q74385813Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis
Q46440437Optically imageable metastatic model of human breast cancer
Q37328110Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo.
Q26744538Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer

Search more.